Citadel Advisors
CME icon

Citadel Advisors’s CME Group CME Stock Holding History

Citadel Advisors’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$110M Sell
373,956
-923,691
-71% -$274M 0.02% 744
2025
Q4 		$354M Buy
1,297,647
+938,015
+261% +$255M 0.05% 280
2025
Q3 		$97.2M Sell
359,632
-387,056
-52% -$105M 0.01% 870
2025
Q2 		$206M Sell
746,688
-117,776
-14% -$32M 0.04% 395
2025
Q1 		$229M Buy
864,464
+509,102
+143% +$126M 0.04% 332
2024
Q4 		$82.5M Sell
355,362
-350,752
-50% -$80.7M 0.01% 862
2024
Q3 		$156M Sell
706,114
-877,660
-55% -$182M 0.03% 470
2024
Q2 		$311M Buy
1,583,774
+1,192,422
+305% +$246M 0.06% 228
2024
Q1 		$84.3M Sell
391,352
-267,127
-41% -$56.1M 0.02% 827
2023
Q4 		$139M Buy
658,479
+210,871
+47% +$45M 0.03% 506
2023
Q3 		$89.6M Sell
447,608
-691,400
-61% -$137M 0.02% 692
2023
Q2 		$211M Sell
1,139,008
-168,393
-13% -$31.1M 0.04% 306
2023
Q1 		$250M Buy
1,307,401
+431,399
+49% +$78M 0.06% 240
2022
Q4 		$147M Sell
876,002
-181,137
-17% -$31.5M 0.03% 466
2022
Q3 		$187M Buy
1,057,139
+482,804
+84% +$95.4M 0.04% 326
2022
Q2 		$118M Buy
574,335
+68,126
+13% +$14.4M 0.03% 493
2022
Q1 		$120M Buy
506,209
+397,891
+367% +$93.4M 0.02% 574
2021
Q4 		$24.7M Sell
108,318
-429,686
-80% -$94.5M 0.01% 1786
2021
Q3 		$104M Buy
538,004
+44,044
+9% +$8.92M 0.02% 638
2021
Q2 		$105M Buy
493,960
+206,801
+72% +$43.7M 0.02% 642
2021
Q1 		$58.6M Buy
287,159
+162,806
+131% +$32.1M 0.01% 922
2020
Q4 		$22.6M Buy
124,353
+4,904
+4% +$834K 0.01% 1671
2020
Q3 		$20M Sell
119,449
-117,927
-50% -$19.9M 0.01% 1566
2020
Q2 		$38.6M Buy
237,376
+130,566
+122% +$23.4M 0.01% 970
2020
Q1 		$18.5M Sell
106,810
-642,999
-86% -$128M 0.01% 1302
2019
Q4 		$151M Sell
749,809
-472,495
-39% -$96.9M 0.07% 253
2019
Q3 		$258M Sell
1,222,304
-148,288
-11% -$31M 0.12% 111
2019
Q2 		$266M Buy
1,370,592
+130,744
+11% +$24.1M 0.12% 101
2019
Q1 		$204M Buy
1,239,848
+713,133
+135% +$126M 0.1% 141
2018
Q4 		$99.1M Buy
526,715
+417,355
+382% +$77.1M 0.05% 324
2018
Q3 		$18.6M Sell
109,360
-102,794
-48% -$17.3M 0.01% 1461
2018
Q2 		$34.8M Sell
212,154
-544,857
-72% -$89M 0.02% 907
2018
Q1 		$122M Buy
757,011
+100,883
+15% +$16.1M 0.07% 249
2017
Q4 		$95.8M Sell
656,128
-1,274,181
-66% -$181M 0.06% 345
2017
Q3 		$262M Buy
1,930,309
+710,804
+58% +$89.8M 0.2% 58
2017
Q2 		$153M Sell
1,219,505
-290,003
-19% -$34.7M 0.13% 127
2017
Q1 		$179M Buy
1,509,508
+1,327,833
+731% +$160M 0.16% 83
2016
Q4 		$21M Sell
181,675
-289,337
-61% -$32.2M 0.02% 844
2016
Q3 		$49.2M Sell
471,012
-880,659
-65% -$91.9M 0.05% 388
2016
Q2 		$132M Buy
1,351,671
+820,177
+154% +$77.5M 0.15% 95
2016
Q1 		$51M Sell
531,494
-1,034,369
-66% -$94.1M 0.06% 294
2015
Q4 		$142M Sell
1,565,863
-488,757
-24% -$46M 0.15% 116
2015
Q3 		$191M Buy
2,054,620
+983,712
+92% +$93.5M 0.18% 91
2015
Q2 		$99.7M Buy
1,070,908
+930,340
+662% +$86.8M 0.09% 238
2015
Q1 		$13.3M Sell
140,568
-99,939
-42% -$9.26M 0.01% 1236
2014
Q4 		$21.3M Sell
240,507
-1,677,916
-87% -$142M 0.02% 900
2014
Q3 		$153M Buy
1,918,423
+789,355
+70% +$59.5M 0.16% 103
2014
Q2 		$80.1M Sell
1,129,068
-532,729
-32% -$37.5M 0.09% 228
2014
Q1 		$123M Buy
1,661,797
+1,235,569
+290% +$93.2M 0.14% 118
2013
Q4 		$33.4M Sell
426,228
-1,324,069
-76% -$104M 0.04% 538
2013
Q3 		$129M Buy
1,750,297
+336,428
+24% +$24.8M 0.2% 86
2013
Q2 		$107M Buy
+1,413,869
New +$92.8M 0.18% 79

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors's CME Position: Q1 2026 in Review

Citadel Advisors reduced its CME Group (CME) stake by 71% in Q1 2026, selling an estimated $274M and leaving 373,956 shares worth $110M. The position accounts for 0.02% of the portfolio, ranked #744.

Citadel Advisors first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $354M in Q4 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Citadel Advisors held 373,956 shares of CME Group worth $110M as of Q1 2026.
  • Citadel Advisors sold 923,691 CME Group shares in Q1 2026, an estimated $274M.
  • CME Group made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #744 holding.
  • Citadel Advisors first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Citadel Advisors's CME Group position peaked at $354M in Q4 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.